Navigation Links
Cephalon Announces Definitive Agreement to Acquire Gemin X
Date:3/21/2011

proval, manufacturing development and capabilities, market prospects for its products, sales and earnings guidance, and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Cephalon does not intend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.

Contacts

Cephalon

Media:
Natalie de Vane
Senior Director, Corporate Communications & Public Affairs
O: 610.727.6536
C. 610.999.8756
ndevane@cephalon.com

Fritz Bittenbender
VP, Public Affairs
O: 610.883.5855
C: 610.457.7041
fbittenb@cephalon.com

Investors:  
Chip Merritt
VP, Investor Relations
610.738.6376
cmerritt@cephalon.com

Joseph Marczely
Manager, Investor Relations
610.883.5894
jmarczely@cephalon.com

Gemin X'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
3. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
4. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
5. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
6. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
7. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
8. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
9. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
10. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
11. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014   , 2014 Second Quarter ... prior year , Overall organic growth was 4% for same ... products; Bausch + Lomb grew 12% , 2014 Second ... 43% , 2014 Second Quarter GAAP Operating Cash Flow ... , Highlights of the Second Quarter , Launched 17 new ...
(Date:7/31/2014)... PARK, N.C. , July 31, 2014 ... Miami facilities to meet the clinical trial ... .  The newly expanded facility will continue to ... consolidation of shipments to and from the region, and ... its newest location, Marken will combine its office and ...
(Date:7/31/2014)... , July 31, 2014 Auxilium ... a specialty biopharmaceutical company, today announced that the ... payment from its partner Asahi Kasei Pharma Corporation ... the successful submission of a regulatory application to ... for XIAFLEX ® (collagenase clostridium histolyticum) for ...
Breaking Medicine Technology:Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 6Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 7Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 8Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 9Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 10Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 11Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 12Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 13Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 14Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 15Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 16Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 17Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 18Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 19Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 20Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 21Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 22Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 23Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 24Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 25Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 26Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 27Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 28Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 29Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 30Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 31Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 32Marken Expands Miami Regional Logistics Center 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4
... , BUDAPEST, Hungary , ... Pfizer Globally Licenses ChemAxon,s Platform For Markush Structure,Searching And Enumeration ... of cheminformatics software for the life,sciences industry has entered into ... functionality for global,development and deployment within Pfizer,s global R&D facilities. ...
... , , , ... The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) ... sclerosis (MS). In clinical trials, patients treated with Ampyra had ... (placebo). This is the first drug approved for this use. ...
Cached Medicine Technology:FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis 2
(Date:7/31/2014)... Some pain relief medications can be as addictive as heroin ... 46 people in the U.S. die from legal pain pills ... to an emergency room because of opioid complications. Consumer ... prescription and over-the-counter painkillers and is calling on the U.S. ... these drugs safer. , The full report, “Deadly Pain Pills” ...
(Date:7/31/2014)... York, NY (PRWEB) July 31, 2014 ... IT solutions firm based in New York City, has ... infrastructure for the midtown Manhattan headquarters of a large ... corporate and investment banking. , Chico Ramnarayan, Chief Executive ... our client is an opportunity for us to further ...
(Date:7/31/2014)... July 31, 2014 Sales in the organic ... to 2014, according to radio talk show host Sharon Kleyne, ... rapid growth since 1990. The US economy in the same ... Power of Water radio show, reported this information following a ... a worldwide manufacturer of organic and natural food products. ...
(Date:7/31/2014)... 2014 Staying happy in a relationship and ... Men and women get sucked into the logistical ruts they ... taxi services to kids. , That’s why Couples in ... + Fun Ways to Reignite the Spark in Your Marriage ... “This is a much better path to happiness, and a ...
(Date:7/31/2014)... 2014 Loffler Companies, the leading business ... recognized by Microsoft as a Microsoft Community Connections Partner ... on July 14, 2014. , The Microsoft U.S. ... that deliver cloud-based IT services and solutions to small ... an U.S. SMB Champions Club member, Loffler has established ...
Breaking Medicine News(10 mins):Health News:Consumer Reports Warns Against the Risks of Prescription and Over-The-Counter Painkillers 2Health News:Consumer Reports Warns Against the Risks of Prescription and Over-The-Counter Painkillers 3Health News:Global Bank Awards CRA with Network Infrastructure Contract 2Health News:Organic Food Industry Grew 12% in 2013-2014 Reports Sharon Kleyne Hour Power of Water Host 2Health News:Organic Food Industry Grew 12% in 2013-2014 Reports Sharon Kleyne Hour Power of Water Host 3Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 2Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 3Health News:Loffler Companies Named Microsoft Community Connections Partner of the Year Award Winner 2Health News:Loffler Companies Named Microsoft Community Connections Partner of the Year Award Winner 3
... not to board a transatlantic flight with a potentially deadly ... and two Czechs who flew with him, media said ... scare two months ago when he flew to Montreal via ... Disease Control (CDC) had said he was infected with a ...
... operation for a rare birth defect has more than one share ... illegal immigrants in the U.S, have also been granted a ... daughter. ,Hazelle Roas little-known genetic abnormality left her with ... kept her in the hospital most of her life. According ...
... tattoo done of their lover's initials due to fear of ... - researchers have discovered a technique, where the cryptic body ... choice. ,The new method is called micro-encapsulation, where ... that are as tiny as pins, can bear a molecule ...
... of foods like white rice, pasta and bread, which ... macular degeneration (AMD). ,However, whole-wheat versions of ... have a low-glycemic-index. These foods are often considered higher ... and less dramatic rise and fall of blood sugar. ...
... turned nasty for a group of around ten ... , A Srilankan group of students who visited ... picnic organized by the Punqudutivu Students Association of Sri Lanka ... and abdominal cramps.,Toronto Public Health on Thursday confirmed six cases ...
... cash in on the Dutch laws. ,The former American ... cookie while touring in the Netherlands. ,"It was ... legal here. I don't ever do anything illegal here, People ... 25-year-old singer said that the cookie was an experiment and ...
Cached Medicine News:Health News:US TB Traveler Sued Over 'reckless and Selfish Behavior' 2Health News:Too Much White Rice, Pasta and Bread may Increase Chances of AMD 2Health News:Too Much White Rice, Pasta and Bread may Increase Chances of AMD 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: